Enveric Biosciences (ENVB) Tax Rate Growth (1y) (2011 - 2024)
Enveric Biosciences (ENVB) Tax Rate Growth (1y) (2011 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Enveric Biosciences | 5.66 Mn | -2.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -84.00 |
| Sep 30, 2020 | 10,970.00 |
| Jun 30, 2020 | 21.00 |
| Mar 31, 2020 | -289.00 |
| Dec 31, 2019 | -2,025.00 |
| Sep 30, 2019 | -309.00 |
| Dec 31, 2018 | 7,473.00 |
| Dec 31, 2017 | 5,942.00 |
| Dec 31, 2016 | 817.00 |
| Mar 31, 2016 | -21.00 |
| Dec 31, 2015 | 531.00 |
| Sep 30, 2015 | 3,609.00 |
| Jun 30, 2015 | 23.00 |
| Mar 31, 2015 | 376.00 |
| Dec 31, 2014 | -1,293.00 |
| Dec 31, 2013 | 2,636.00 |
| Dec 31, 2012 | -104.00 |
| Dec 31, 2011 | 329.00 |